Citations

Mayo Clinic

Showing 10 of 108585 citations.

The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC‐derived cardiomyocytes
Necela, Brian M. , Axenfeld, Bianca C., Serie, Daniel, Kachergus, Jennifer M., Perez, Edith A., Thompson, E. Aubrey , Norton, Nadine , Serie, Daniel J, Perez, Edith A. , Norton, Nadine

Clinical and Translational Medicine | January 18, 2017 | Volume: 6 | Issue: 1 | Pages: No page available

10.1186/s40169-016-0133-2 | PMID 28101782 Get It

AbstractBackgroundThe targeted ERBB2 therapy, trastuzumab, has had a tremendous impact on management of patients with HER2+ breast cancer, leading to development and increased use of further HER2 targeted therapies. The major clinical side effect is cardiotoxicity but the mechanism is largely unknown. On the basis that gene expression is known to be altered in multiple models of heart failure, we examined differential gene expression of iPSC‐derived cardiomyocytes treated at day 11 with the ERBB2 targeted monoclonal antibody, trastuzumab for 48 h and the small molecule tyrosine kinase inhibitor of EGFR and ERBB2.ResultsTranscriptome sequencing was performed on four replicates from each group (48 h untreated, 48 h trastuzumab and 48 h lapatinib) and differential gene expression analyses were performed on each treatment group relative to untreated cardiomyocytes. 517 and 1358 genes were differentially expressed, p < 0.05, respectively in cardiomyocytes treated with trastuzumab and lapatinib. Gene ontology analyses revealed in cardiomyocytes treated with trastuzumab, significant down‐regulation of genes involved in small molecule metabolism (p = 3.22 × 10−9) and cholesterol (p = 0.01) and sterol (p = 0.03) processing. We next measured glucose uptake and lactate production in iPSC‐derived cardiomyocytes 13 days post‐plating, treated with trastuzumab up to 96 h. We observed significantly decreased glucose uptake from the media of iPSC‐derived cardiomyocytes treated with trastuzumab as early as 24 h (p = 0.001) and consistently up to 96 h (p = 0.03).ConclusionsOur study suggests dysregulation of cardiac gene expression and metabolism as key elements of ERBB2 signaling that could potentially be early biomarkers of cardiotoxicity.
Faculty Opinions recommendation of Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosome.
Maher, Jim

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 18, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726976418.793527230 Get It

Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies
Simpson, Claire L. , Andrade, Mariza de , Mandal, Diptasri , Gaba, Colette , Li, Yafang , You, Ming , Kupert, Elena, Anderson, Marshall W., Schwartz, Ann G. , Pinney, Susan M. , Bailey‐Wilson, Joan E. , de Andrade, Mariza, Musolf, Anthony M. , Yang, Ping , Amos, Christopher I. , de Andrade, Mariza , Wilson, Richard K , Pinney, Susan M

Genes | January 18, 2017 | Volume: 8 | Issue: 1 | Pages: 36

10.3390/genes8010036 | PMID 28106732 Get It

Lung cancer is the deadliest cancer in the United States, killing roughly one of four cancer patients in 2016. While it is well-established that lung cancer is caused primarily by environmental effects (particularly tobacco smoking), there is evidence for genetic susceptibility. Lung cancer has been shown to aggregate in families, and segregation analyses have hypothesized a major susceptibility locus for the disease. Genetic association studies have provided strong evidence for common risk variants of small-to-moderate effect. Rare and highly penetrant alleles have been identified by linkage studies, including on 6q23–25. Though not common, some germline mutations have also been identified via sequencing studies. Ongoing genomics studies aim to identify additional high penetrance germline susceptibility alleles for this deadly disease.
Air Embolism: Diagnosis, Clinical Management and Outcomes
McCarthy, C. F., Behravesh, Sasan , Naidu, Sailendra , Öklü, Rahmi , Naidu, Sailendra G, Oklu, Rahmi

Diagnostics | January 18, 2017 | Volume: 7 | Issue: 1 | Pages: 5

10.3390/diagnostics7010005 | PMID 28106717 Get It

Air embolism is a rare but potentially fatal complication of surgical procedures. Rapid recognition and intervention is critical for reducing morbidity and mortality. We retrospectively characterized our experience with air embolism during medical procedures at a tertiary medical center. Electronic medical records were searched for all cases of air embolism over a 25-year period; relevant medical and imaging records were reviewed. Sixty-seven air embolism cases were identified; the mean age was 59 years (range, 3–89 years). Ninety-four percent occurred in-hospital, of which 77.8% were during an operation/invasive procedure. Vascular access-related procedures (33%) were the most commonly associated with air embolism. Clinical signs and symptoms were related to the location the air embolus; 36 cases to the right heart/pulmonary artery, 21 to the cerebrum, and 10 were attributed to patent foramen ovale (PFO). Twenty-one percent of patients underwent hyperbaric oxygen therapy (HBOT), 7.5% aspiration of the air, and 63% had no sequelae. Mortality rate was 21%; 69% died within 48 hours. Thirteen patients had immediate cardiac arrest where mortality rate was 53.8%, compared to 13.5% (p = 0.0035) in those without. Air emboli were mainly iatrogenic, primarily associated with endovascular procedures. High clinical suspicion and early treatment are critical for survival.
FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype
Barrett, Rachel, Morash, Barbara, Roback, David W., Pambrun, Chantale , Marfleet, Lesley, Ketterling, Rhett P. , Harrison, Karen J., Berman, Jason N. , Ketterling, Rhett P

Pediatric Blood & Cancer | January 18, 2017 | Volume: 64 | Issue: 8 | Pages: No page available

10.1002/pbc.26450 | PMID 28097792 Get It

AbstractCytogenetics can inform risk stratification in pediatric acute myeloid leukemia (AML). We describe the first case of a newborn with leukemia cutis found to have AML harboring a cryptic insertional t(8;16)(p11.2;p13.3) with associated KAT6A/CREBBP fusion identified exclusively by fluorescence in situ hybridization (FISH). Expectant management resulted in spontaneous leukemia resolution. The identification of t(8;16)(p11.2;p13.3) may serve as a biomarker for spontaneous remission in congenital AML. FISH for this translocation is warranted in congenital AML with a normal karyotype, and patients with KAT6A/CREBBP fusion should be conservatively managed. While 50% of spontaneously remitting congenital AML with t(8;16)(p11.2;p13.3) may recur, high salvage rates are attained with standard therapy.
Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease
Wijarnpreecha, Karn , Panjawatanan, Panadeekarn , Jaruvongvanich, Veeravich , Ungprasert, Patompong , Thongprayoon, Charat , Manatsathit, Wuttiporn , Wijarnpreecha, Karn

Journal of Clinical Gastroenterology | January 18, 2017 | Volume: 52 | Issue: 5 | Pages: 386-391

10.1097/mcg.0000000000000784 | PMID 28098578 Get It

Background/Objectives: Helicobacter pylori (H. pylori) is the most common chronic bacterial infection. Patients with H. pylori infection may be at an increased risk of nonalcoholic fatty liver disease (NAFLD) because of chronic inflammation and insulin resistance. Several epidemiologic studies attempting to determine this risk have yielded inconsistent results. This meta-analysis was conducted with the aims to summarize all available evidence and estimate the risk of NAFLD in patients with H. pylori infection. Methods: A literature search was performed using MEDLINE and EMBASE database from inception to June 2016. Studies that reported relative risks, odd ratios, or hazard ratios comparing the risk of NAFLD among patients with H. pylori infection versus without H. pylori infection were included. Pooled odds ratios and 95% confidence intervals were calculated using a random-effect, generic inverse variance method. Results: Six studies met our eligibility criteria and were included in this analysis. We found a statistically significant increased risk of NAFLD among patients with H. pylori infection with the pooled odds ratios of 1.21 (95% confidence interval, 1.07-1.37). The statistical heterogeneity was low with an I 2 of 49%. Conclusions: A significantly increased risk of NAFLD among patients with H. pylori infection was demonstrated in this meta-analysis. Further studies are required to clarify how this risk should be addressed in clinical practice.
Median Lingual Lymph Nodes: Prevalence on Imaging and Potential Implications for Oral Cavity Cancer Staging
Tomblinson, Courtney M. , Nagel, Thomas H. , Hu, Leland , Zarka, Matthew A., Hoxworth, Joseph M.

Journal of Computer Assisted Tomography | January 18, 2017 | Volume: 41 | Issue: 4 | Pages: 528-534

10.1097/rct.0000000000000568 | PMID 28099223 Get It

Objective This study sought to estimate the prevalence of median lingual lymph node (MLLN) metastases from oral cavity squamous cell carcinoma (OCSCC) and determine the frequency with which MLLNs can be identified with magnetic resonance imaging (MRI) in control subjects. Methods Pathology reports were used to identify patients with surgically treated OCSCC who underwent preoperative positron emission tomography–computed tomography to define the prevalence of MLLN metastases. As a control group, 500 consecutive face-neck MRIs from noncancer patients were reviewed for structures consistent with MLLNs. Results In the study group, 1 (0.95%) of 105 OCSCC cases demonstrated a single MLLN metastasis from a lateral tongue tumor (T4aN2c). The MLLN exceeded 1 cm in all planes and was abnormal in morphology. The frequency of suspected MLLNs in controls was 1.0%, with a maximum measurement of 0.9 cm. Conclusions Median lingual lymph nodes are infrequently identified with MRI in controls, concordant with the low prevalence of metastases from OCSCC to this inconstant nodal group.
Signalling pathways involved in hypoxia‐induced renal fibrosis
Liu, Minna , Ning, Xiaoxuan , Li, Rong , Yang, Zhen , Yang, Xiaoxia , Sun, Shiren , Qian, Qi

Journal of Cellular and Molecular Medicine | January 18, 2017 | Volume: 21 | Issue: 7 | Pages: 1248-1259

10.1111/jcmm.13060 | PMID 28097825 Get It

Abstract Renal fibrosis is the common pathological hallmark of progressive chronic kidney disease ( CKD ) with diverse aetiologies. Recent researches have highlighted the critical role of hypoxia during the development of renal fibrosis as a final common pathway in end‐stage kidney disease ( ESKD ), which joints the scientist's attention recently to exploit the molecular mechanism underlying hypoxia‐induced renal fibrogenesis. The scaring formation is a multilayered cellular response and involves the regulation of multiple hypoxia‐inducible signalling pathways and complex interactive networks. Therefore, this review will focus on the signalling pathways involved in hypoxia‐induced pathogenesis of interstitial fibrosis, including pathways mediated by HIF , TGF ‐β, Notch, PKC / ERK , PI 3K/Akt, NF ‐κB, Ang II / ROS and micro RNA s. Roles of molecules such as IL ‐6, IL ‐18, KIM ‐1 and ADO are also reviewed. A comprehensive understanding of the roles that these hypoxia‐responsive signalling pathways and molecules play in the context of renal fibrosis will provide a foundation towards revealing the underlying mechanisms of progression of CKD and identifying novel therapeutic targets. In the future, promising new effective therapy against hypoxic effects may be successfully translated into the clinic to alleviate renal fibrosis and inhibit the progression of CKD .
Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients
Khera, Sahil , Aronow, Wilbert S. , Cooper, Howard A., Rihal, Charanjit S. , Panza, Julio A. , Bhatt, Deepak L. , Gupta, Tanush , Kolte, Dhaval , Goel, Kashish , Jain, Diwakar , Rihal, Charanjit S. , Fonarow, Gregg C. , Bhatt, Deepak L

JAMA Cardiology | January 18, 2017 | Volume: 2 | Issue: 3 | Pages: 250

10.1001/jamacardio.2016.5131 | PMID 28097322 Get It

The Missing Record of Mental Status in Written Sign-Outs
Croix, Michael , Miller, Donna , Whittle, Jeff , Singh, Siddhartha , Schapira, Marilyn M. , Kuester, Jessica, Kallio, Christa, Framberg, Susan, Fletcher, Kathlyn E. , Miller, Donna M , Carnahan, Jennifer L.

Journal of Patient Safety | January 18, 2017 | Volume: 15 | Issue: 4 | Pages: e40-e43

10.1097/pts.0000000000000280 | PMID 28098585 Get It

Objective The aim of the study was to determine how frequently mental status and mental status changes are documented in the written patient summary (“sign-out”) provided to covering physicians. Patients and Methods This was a retrospective cohort study of general medical patients hospitalized between March 16, 2009, and March 15, 2010, conducted at 2 teaching hospitals. Participants included patients with mental status change adverse events (MSAEs) and their providers. Chart review was performed to identify patients with MSAEs and details about these events. Sign-outs were reviewed for documentation of mental status. Main outcome measures were (1) proportion of patients with MSAEs who had mental status ever recorded in sign-out entries and (2) the proportion of patients with MSAEs whose change in mental status was recorded in the sign-out. Results Sixty-eight patients had MSAEs and were included in the sample. Fifty percent of MSAEs were attributed to medications; 75% of these events were first detected by nurses. Only 25% of patients with MSAEs had their change in mental status recorded in sign-outs. Conclusions Recording mental status in written sign-outs is uncommon. Particularly concerning is that patients with MSAEs identified by chart review seldom had sign-outs that reflected those events. Interventions should be designed to increase the recording of this information in sign-outs.